2025 Partners

Promega

Innovation Partner

Learn More

Promega provides a broad portfolio of functional bioassays and immunoassays to accelerate your cell therapy development programs. We offer state-of-the-art reporter and cell health assays for potency testing along with a suite of cytokine immunoassays for the detection of critical cell therapy analytes. All our products are developed and manufactured under rigorous quality standards and our bioassays are pre-qualified according to ICH guidelines.

www.promega.com

Thermo Fisher

Innovation Partner

Learn More

As the world leader in serving science, Thermo Fisher Scientific is uniquely positioned to provide the quality materials, services and support need to accelerate the pace of cell and gene therapy development. Partner with us to access the high-quality materials, services, and support you need from discovery to clinical research and commercial cell and gene manufacturing. Through our diverse portfolio of brands, we offer an unmatched combination of innovative technologies, manufacturing, and distribution capabilities.

www.thermofisher.com

BioIVT

Exhibition Partner

Learn More

BioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to life science and diagnostic industries. Recognized as an industry leader, BioIVT specializes in control and disease state samples including human and animal tissues or preparations, ADME-Tox products and research services, cell and gene therapy products, blood, and other biofluids.

www.bioivt.com

Biocytogen

Exhibition Partner

Learn More

Biocytogen is a global biotech company advancing antibody drug development through innovative technologies. Leveraging gene-editing expertise, it pioneered drug target knock-in humanized models and offers 3,000+ models via BioMice™, along with in vivo, ex vivo, and in vitro pharmacology and custom gene-editing services. Biocytogen drives fully human monoclonal antibody discovery and offers 400,000+ antibody sequences targeting 1,000 proteins through its RenBiologics™ sub-brand for global partnerships.

www.biocytogen.com

CytoAgents

Industry Partner

Learn More

Cytoagents is a clinical stage therapeutics company developing CTO1681, an oral small molecule immune modulator to prevent and treat Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) by tamping down excessive inflammation by downregulating cytokine production and restoring normal immune function. By effectively preventing CRS in CAR T-Cell Therapy and then expanding into other immunotherapies, CytoAgents will remove one of the major obstacles standing in the way of widescale adoption of these breakthrough therapies. CTO1681 is currently conducting a Phase 1b/2a Clinical Trial in Lymphoma Patients Receiving CART at Risk for CRS and ICANS.

www.cytoagents.com

Innorna

Event Partner

Learn More

Innorna is a clinical-stage biotech advancing RNA medicines through proprietary lipid nanoparticle (LNP) delivery and mRNA platform technologies. With vertically integrated in-house capabilities spanning IP generation, discovery, process development, and cGMP-scale manufacturing, Innorna enables rapid translation from concept to clinic.

Its rationally designed library of over 6,000 ionizable lipids supports diverse delivery applications through structure-activity relationship optimization. The company holds a global portfolio of more than 100 patents—granted and pending—covering innovations in LNP and RNA platforms.

Innorna’s pipeline addresses unmet medical needs across infectious diseases, oncology, chronic disease, rare disorders, and autoimmune conditions. Learn more at www.innorna.com

Beacon

Research Partner

Learn More

Full Event Guide

Partner With Us

December 2-4, 2025 | Philadelphia, PA

December 2-4, 2025 | Philadelphia, PA

2025 Partners

Promega

Thermo Fisher

BioIVT

Biocytogen

CytoAgents

Innorna

Beacon

VENUE

LOCATION

OUR CONTACT DETAILS

JOIN OUR TEAM

ABOUT US

EXPLORE OUR PRODUCTS

LATEST CELL & GENE THERAPY EVENT SERIES NEWs

SEARCH